Rome, October 21 (askanews) – Starting from patient concerns, we must foster a system capable of recognizing healthcare not just as an expense, but as a strategic investment for Italy's future. This is the vision at the heart of Patient Council 2026, a Sanofi initiative developed with the support of Luiss Business School, which involved more than 25 patient associations in a process of analysis, discussion, advocacy, and co-design. Matteo Caroli, Associate Dean for Sustainability and Impact at Luiss Business School: "The fundamental transformation is to move from a concept of healthcare spending to an investment in healthcare, which obviously generates a social return, but also an economic return.
Implementation means first and foremost understanding where to focus these investments, and the work we've done together with Sanofi at Louis Business School highlights the importance of clinical research. Therefore, we need to focus our efforts and aim for maximum efficiency." The process was developed together with patient associations, who were called upon to actively contribute to identifying needs and priorities for discussion with the institutions. Marcello Cattani, President and CEO of Sanofi Italy and Malta: "It's essential to have a dialogue, it's essential to build paths and strategies together, precisely because today's world requires a shared purpose.
Innovation requires investment in research and development, a strong impact from the innovation that Sanofi is making in Italy." The Patient Council 2026 developed through several workshops, designed and conducted with Luiss Business School, to jointly define a Manifesto aimed at defining priorities and concrete requests. Matteo Caroli, Associate Dean for Sustainability and Impact at Luiss Business School: "We provided a scientific basis of data and robust evidence, which was essential for the second phase of dialogue with patient associations and medical associations.
We listened to their perspectives and priorities, and then we discussed this final manifesto with Sanofi again. Among the conclusions of the process were recognizing health as a driver of growth and creating conditions that foster innovation, research, clinical trials, and access to care.
Askanews